Jun 22, 2024, 02:02
Sameh Abdelmalak: Dr. Giuseppe Curigliano discussing ASCO24 DESTINY-Breast06
Sameh Abdelmalak, Director, Oncology, Educational Partnerships at VuMedi, made the following post on X:
“Check out Check out Dr. Giuseppe Curigliano, discussing ASCO24 ‘DESTINY-Breast06 – T-DXd vs. Physician’s Choice of Chemotherapy in HR+/HER2-Low/Ultralow mBC After Endocrine Therapy’.
Full video on VuMedi.”
Video attached to the post.
Source: Sameh Abdelmalak/X
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Sep 28, 2024, 07:32
Sep 28, 2024, 07:26
Sep 28, 2024, 07:23
Sep 28, 2024, 07:08
Sep 28, 2024, 07:02
Sep 28, 2024, 06:42
Sep 28, 2024, 06:41
Sep 28, 2024, 06:36